Using Data and Analytics to Build Better Products

In 2016, we really started to get access to data sets that weren't on the market yet. I had spent a lot of my time really understanding how de-identified patient-level data was being used across the industry. A lot of payer-derived data is not infused in the way pharmaceutical companies work for a lot of reasons. And so through that processreally understood the sampling bias of a lot of provider- derived systems.